Flat.Bio

Chinese gene-editing researcher Dr He Jianku, who reportedly created two gene-edited babies, starts lab in Beijing for gene therapy research, after serving 3-year jail sentence

28 Nov 2022 • 12:21 PM EST,

PermaLink

Staff Writer

Pandaily

China reports 3 cases of Covid deaths, the first time since May lockdown. With rising cases and outbreaks, the country may again tighten harsh Covid restrictions that were just eased. Markets fear further economic impact

21 Nov 2022 • 11:30 AM EST,

PermaLink

Phoebe Zhang

South China Morning Post

Merck to acquire cancer drug company Imago BioSciences for $1.35 billion to expand its portfolio to bone marrow diseases

21 Nov 2022 • 11:05 AM EST,

PermaLink

Raghav Mahobe

Reuters

FDA approves the first 'game-changing' treatment that delays onset of Type 1 diabetes. The drug, teplizumab, is developed New Jersey-based Provention Bio

19 Nov 2022 • 11:35 AM EST,

PermaLink

Adrianna Rodriguez

USA Today

Elizabeth Holmes, the Founder & former CEO of blood testing startup Theranos, sentenced to 11 years & three months in prison for fraud

19 Nov 2022 • 10:29 AM EST,

PermaLink

Condé Nast

Vogue

Eisai & Biogen's drug lecanemab for Alzheimer's disease shown to slow disease progress by 27% compared with a placebo, in a 1795-patient landmark clinical trial

28 Sep 2022 • 4:50 PM EDT,

PermaLink

Rebecca Robbins

New York Times

High profile gene editing startup Prime Medicine files for IPO

26 Sep 2022 • 4:45 PM EDT,

PermaLink

Ben Fidler

BioPharma Dive

When the Fed's fight inflation and stock market is struggling, biotech may offer a line of hope

21 Sep 2022 • 5:12 PM EDT,

PermaLink

Investor'S Business Daily

Investor's Business Daily

Catalent, one of the major pharma contract manufacturers, was cited by FDA for quality issues at its Covid-19 vaccine production site in Indiana

21 Sep 2022 • 5:27 PM EDT,

PermaLink

Tyler Patchen

Endpoints News

BrainStorm to seek FDA approval for its amyotrophic lateral sclerosis drug NurOwn. FDA rejected NurOwn last year. The company re-analyzed its phase III data, made corrections, and re-submitted to the Agency

15 Aug 2022 • 11:25 AM EDT,

PermaLink

Heather McKenzie

BioSpace

Monkeypox, whose transition once believed as self-limiting, forces researchers to re-learn how it spreads differently now, as cases ballooning rapidly around the globe (- Statnews)

15 Aug 2022 • 10:30 AM EDT,

PermaLink

Megan Molteni

STAT

Pfizer CEO tests positive on Covid, experiencing mild symptoms, is on Pfizer's Covid drug Paxlovid

15 Aug 2022 • 9:47 AM EDT,

PermaLink

Reuters Staff

The Jerusalem Post | JPost.com

Monkeypox cases spreading in 20 countries of Europe, North America, and South America. The World Health Organization describes the epidemic as “containable”

27 May 2022 • 5:13 PM EDT,

PermaLink

Maria Cheng

AP - The Associated Press

Pfizer and BioNTech's Covid vaccine shown a booster (third) shot in children of 5 to 11 years had 36X increase in Omicron neutralizing titers, and other increased immune responses. The companies to seek FDA authorization

14 Apr 2022 • 11:12 AM EDT,

PermaLink

Julia Musto

Fox News

Renowned Harvard stem cell scientist to head Vertex Pharmaceuticals' type 1 diabetes drug that may cure the disease

05 Apr 2022 • 5:07 PM EDT,

PermaLink

Kyle LaHucik

Endpoints News

Covid: as US cases decline and restrictions ease, Europe and Asia see cases surging with China re-instates lockdown in some areas and cities

15 Mar 2022 • 12:14 PM EDT,

PermaLink

Erik Ortiz

NBC

Moderna reports big 4Q 2021 earnings: $7.2 billion in revenue & $11.29 in EPS, beating Wall Street expectations. The Company expects $19 billion Covid vaccine sales for 2022. European Medicines Agency issues positive opinion for use in children

24 Feb 2022 • 11:40 AM EST,

PermaLink

CNBC

YouTube

For doctors, there are a few treatment options now for Covid, namely anti-inflammatory steroid dexamethasone, antiviral, and monoclonal antibody

23 Feb 2022 • 12:25 AM EST,

PermaLink

Fergus Walsh

BBC

Regeneron's antibody drug shown one single dose provides COVID protection for up to 8 months, potentially an alternative for people who are hesitant to get vaccines

08 Nov 2021 • 9:03 AM EST,

PermaLink

CNBC

YouTube

Pfizer's Covid drug combined with HIV drug shown cutting the risk of hospitalization or death by 89%. Gottlieb: Covid pandemic could be over in the US by January

05 Nov 2021 • 12:09 PM EDT,

PermaLink

Rebecca Robbins

New York Times

Archived Story

Regeneron's antibody drug shown one single dose provides COVID protection for up to 8 months, potentially an alternative for people who are hesitant to get vaccines

Top News

Chinese gene-editing researcher Dr He Jianku, who reportedly created two gene-edited babies, starts lab in Beijing for gene therapy research, after serving 3-year jail sentence

China reports 3 cases of Covid deaths, the first time since May lockdown. With rising cases and outbreaks, the country may again tighten harsh Covid restrictions that were just eased. Markets fear further economic impact

Merck to acquire cancer drug company Imago BioSciences for $1.35 billion to expand its portfolio to bone marrow diseases

FDA approves the first 'game-changing' treatment that delays onset of Type 1 diabetes. The drug, teplizumab, is developed New Jersey-based Provention Bio

Elizabeth Holmes, the Founder & former CEO of blood testing startup Theranos, sentenced to 11 years & three months in prison for fraud

Eisai & Biogen's drug lecanemab for Alzheimer's disease shown to slow disease progress by 27% compared with a placebo, in a 1795-patient landmark clinical trial

High profile gene editing startup Prime Medicine files for IPO

When the Fed's fight inflation and stock market is struggling, biotech may offer a line of hope

Catalent, one of the major pharma contract manufacturers, was cited by FDA for quality issues at its Covid-19 vaccine production site in Indiana

BrainStorm to seek FDA approval for its amyotrophic lateral sclerosis drug NurOwn. FDA rejected NurOwn last year. The company re-analyzed its phase III data, made corrections, and re-submitted to the Agency

Monkeypox, whose transition once believed as self-limiting, forces researchers to re-learn how it spreads differently now, as cases ballooning rapidly around the globe (- Statnews)

Pfizer CEO tests positive on Covid, experiencing mild symptoms, is on Pfizer's Covid drug Paxlovid

Monkeypox cases spreading in 20 countries of Europe, North America, and South America. The World Health Organization describes the epidemic as “containable”

Pfizer and BioNTech's Covid vaccine shown a booster (third) shot in children of 5 to 11 years had 36X increase in Omicron neutralizing titers, and other increased immune responses. The companies to seek FDA authorization

Renowned Harvard stem cell scientist to head Vertex Pharmaceuticals' type 1 diabetes drug that may cure the disease

Covid: as US cases decline and restrictions ease, Europe and Asia see cases surging with China re-instates lockdown in some areas and cities

Moderna reports big 4Q 2021 earnings: $7.2 billion in revenue & $11.29 in EPS, beating Wall Street expectations. The Company expects $19 billion Covid vaccine sales for 2022. European Medicines Agency issues positive opinion for use in children

For doctors, there are a few treatment options now for Covid, namely anti-inflammatory steroid dexamethasone, antiviral, and monoclonal antibody

Regeneron's antibody drug shown one single dose provides COVID protection for up to 8 months, potentially an alternative for people who are hesitant to get vaccines

Pfizer's Covid drug combined with HIV drug shown cutting the risk of hospitalization or death by 89%. Gottlieb: Covid pandemic could be over in the US by January

Latest News

Chinese Gene-Editing Scientist He Jiankui Sets Up Beijing Lab Following Prison Release

Guangzhou Covid-19: China locks down key transportation hub; markets fear economic fallout

Beijing facing 'most severe Covid test' as China reports first deaths in six months

Updated: No Seagen here: 'Do more' means a small $1.35B purchase of Imago for Merck

Merck to buy Imago BioSciences for $1.35 billion

Coronavirus: Beijing moves teaching online, urges people to stay home while testing China’s shift from strict measures

Merck to buy Imago for $1.35 bln to broaden portfolio of blood disorder drugs

Beijing COVID cases continue to rise

China reports first Covid deaths since May lockdown in Shanghai

FDA approves first treatment that delays Type 1 diabetes. Why it could be 'game changing'